Clinical and research markers of oxidative stress in chronic kidney disease

References

• Agarwal R. (2003). Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol Renal Physiol 284:F863–9
   PubMed Web of Science ®Google Scholar
• AIHW. (2007). Health expenditure Australia 2005–06. Canberra: Australian Institute of Health and Welfare
   Google Scholar
• AIHW. (2009). Health care expenditure on chronic kidney disease in Australia 2004–05. Canberra: Australian Institute of Health and Welfare
   Google Scholar
• Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, et al. (2007). Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 23:242–7
   PubMed Web of Science ®Google Scholar
• Anderson JW, Konz EC. (2001). Obesity and disease management: effects of weight loss on comorbid conditions. Obesity Res 9:326S–34S
   Google Scholar
• Annuk M, Fellstrom B, Akerblom O, et al. (2001a). Oxidative stress markers in pre-uremic patients. Clin Nephrol 56:308–14
   PubMed Web of Science ®Google Scholar
• Annuk M, Soveri I, Zilmer M, et al. (2005). Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol 18:721–6
   PubMed Web of Science ®Google Scholar
• Annuk M, Zilmer M, Lind L, et al. (2001b). Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12:2747–52
   PubMed Web of Science ®Google Scholar
• Antolini F, Valente F, Ricciardi D, et al. (2005). Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin Chim Acta 358:87–94
   PubMed Web of Science ®Google Scholar
• Antolovich M, Prenzler PD, Patsalides E, et al. (2002). Methods for testing antioxidant activity. Analyst 127:183–98
   PubMed Web of Science ®Google Scholar
• Apeland T, Mansoor MA, Seljeflot I, et al. (2002). Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy. J Intern Med 252:456–64
   PubMedGoogle Scholar
• Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. (1996). The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 56:41–6
   PubMed Web of Science ®Google Scholar
• Aslam S, Santha T, Leone A, Wilcox C. (2006). Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int 70:2109–15
   PubMed Web of Science ®Google Scholar
• Atalay M, Laaksonen DE, Niskanen L, et al. (1997). Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand 161:195–201
   PubMedGoogle Scholar
• Atamer A, Kocyigit Y, Ecder SA, et al. (2008). Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. J Nephrol 21:924–30
   PubMedGoogle Scholar
• Aveles PR, Criminacio CR, Goncalves S, et al. (2010). Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Nephron Clin Pract 116:c294–9
   PubMedGoogle Scholar
• Aygen B, Celiker H, Dogukan A, Ilhan N. (2008). The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease. Methods Find Exp Clin Pharmacol 30:757–60
   Google Scholar
• Baragetti I, Raselli S, Stucchi A, et al. (2007). Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration. Nephrol Dial Transplant 22:3292–7
   Google Scholar
• Basu S. (2007). The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target. Scand J Food Nutr 51:48–61
   Google Scholar
• Beltrami C, Clayton A, Phillips AO, et al. (2012). Analysis of urinary microRNAs in chronic kidney disease. Biochem Soc Trans 40:875–9
   PubMedGoogle Scholar
• Berlett BS, Stadtman ER. (1997). Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–16
   PubMed Web of Science ®Google Scholar
• Biasioli S, Schiavon R, Petrosino L, et al. (2001). Do different dialytic techniques have different atherosclerotic and antioxidant activities? ASAIO J 47:516–21.
   Google Scholar
• Biasioli S, Schiavon R, Petrosino L, et al. (1997). Free radicals and oxidative stress challenge dialysis patients: effects of two different membranes. ASAIO J 43:M766–72
   PubMedGoogle Scholar
• Billings FTT, Ball SK, Roberts LJ, et al. (2011). Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med 50:1480–7
   PubMed Web of Science ®Google Scholar
• Bober J, Kedzierska K, Kwiatkowska E, et al. (2010). Does oxidative stress affect the activity of the sodium-proton exchanger? Ann Acad Med Stetin 56:5–12.
   Google Scholar
• Bogdanov MB, Beal MF, McCabe DR, et al. (1999). A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2′-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. Free Radic Biol Med 27:647–66
   PubMed Web of Science ®Google Scholar
• Bordoni V, Piroddi M, Galli F, et al. (2006). Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif 24:149–56
   Web of Science ®Google Scholar
• Bostom AG, Shemin D, Verhoef P, et al. (1997). Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: a prospective study. Arterioscler Thromb Vasc Biol 17:2554–8
   PubMed Web of Science ®Google Scholar
• Bouzidi N, Mekki K, Boukaddoum A, et al. (2010). Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. J Ren Nutr 20:321–8
   Google Scholar
• Bowling CB, Feller MA, Mujib M, et al. (2011). Relationship between stage of kidney disease and incident heart failure in older adults. Am J Nephrol 34:135–41
   Google Scholar
• Burke-Gaffney A, Callister ME, Nakamura H. (2005). Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26:398–404
   PubMed Web of Science ®Google Scholar
• Cadet J, Douki T, Ravanat JL. (2010). Oxidatively generated base damage to cellular DNA. Free Radic Biol Med 49:9–21
   PubMed Web of Science ®Google Scholar
• Canestrari F, Buoncristiani U, Galli F, et al. (1995). Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 234:127–36
   PubMed Web of Science ®Google Scholar
• Cass A, Chadban S, Gallagher M, et al. (2010). The economic impact of end stage kidney disease in Australia: Projections to 2020. Melbourne: Kidney Health Australia
   Google Scholar
• Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, et al. (1996). Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21:845–53
   PubMed Web of Science ®Google Scholar
• Cevat Inal T, Tuli A, Yuregir GT. (1996). Evaluation of reference values for erythrocyte glutathione. Clin Chim Acta 256:189–96
   Google Scholar
• Chang JW, Lee EK, Kim TH, et al. (2007). Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. Am J Nephrol 27:70–4
   PubMed Web of Science ®Google Scholar
• Chatterjee SR, Srivastava TS, Kamat JP, Devasagayam TP. (1997a). Lipid peroxidation induced by a novel porphyrin plus light in isolated mitochondria: possible implications in photodynamic therapy. Mol Cell Biochem 166:25–33
   PubMed Web of Science ®Google Scholar
• Chatterjee SR, Srivastava TS, Kamat JP, Devasagayam TP. (1997b). Lipid peroxidation induced by meso-tetrakis[3,4-bis(carboxymethyleneoxy)phenyl] porphyrin on photosensitization in hepatic and tumor microsomes. Chem Biol Interact 108:27–37
   PubMed Web of Science ®Google Scholar
• Chen J, Muntner P, Hamm LL, et al. (2004). The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–74
   PubMed Web of Science ®Google Scholar
• Coaccioli S, Standoli ML, Biondi R, et al. (2010). Open comparison study of oxidative stress markers between patients with chronic renal failure in conservative therapy and patients in haemodialysis. Clin Ter 161:435–9
   Google Scholar
• Collins AR. (2004). The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–61
   PubMed Web of Science ®Google Scholar
• Cooke MS, Evans MD, Dizdaroglu M, Lunec J. (2003). Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–214
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Giustarini D, Colombo R, et al. (2003a). Protein carbonylation in human diseases. Trends Mol Med 9:169–76
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Giustarini D, et al. (2003b). Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23–38
   PubMed Web of Science ®Google Scholar
• de Cavanagh EM, Ferder L, Carrasquedo F, et al. (1999). Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am J Kidney Dis 34:445–55
   PubMed Web of Science ®Google Scholar
• de Vecchi AF, Bamonti F, Novembrino C, et al. (2009). Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. Nephrol Dial Transplant 24:2524–9
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. (2005). A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15:316–28
   PubMed Web of Science ®Google Scholar
• Domenici FA, Vannucchi MT, Jordao AA, et al. (2005). DNA oxidative damage in patients with dialysis treatment. Ren Fail 27:689–94
   PubMed Web of Science ®Google Scholar
• Dounousi E, Papavasiliou E, Makedou A, et al. (2006). Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48:752–60
   PubMed Web of Science ®Google Scholar
• Drai J, Bannier E, Chazot C, et al. (2001). Oxidants and antioxidants in long-term haemodialysis patients. Farmaco 56:463–5
   PubMedGoogle Scholar
• Eiselt J, Racek J, Opatrny K Jr. (2000). Oxidative stress: the effect of erythropoietin and the dialysis membrane. Int J Artif Organs 23:33–40
   Google Scholar
• Emre H, Keles M, Yildirim S, et al. (2011). Comparison of the oxidant-antioxidant parameters and sialic acid levels in renal transplant patients and peritoneal dialysis patients. Transplant Proc 43:809–12
   PubMed Web of Science ®Google Scholar
• Ersson C, Thorman R, Rodhe Y, et al. (2011). DNA damage in salivary gland tissue in patients with chronic kidney disease, measured by the comet assay. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:209–15
   Google Scholar
• Fatouros IG, Douroudos I, Panagoutsos S, et al. (2010). Effects of l-carnitine on oxidative stress responses in patients with renal disease. Med Sci Sports Exerc 42:1809–18
   PubMed Web of Science ®Google Scholar
• Fatouros IG, Pasadakis P, Sovatzidis A, et al. (2008). Acute exercise may exacerbate oxidative stress response in hemodialysis patients. Nephron Clin Pract 109:c55–64
   Google Scholar
• Fragedaki E, Nebel M, Schupp N, et al. (2005). Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant 20:1936–43
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Nakamura T, Sato E, et al. (2011). Renovascular protective effects of erythropoietin in patients with chronic kidney disease. Intern Med 50:1929–34
   Google Scholar
• Furuya R, Kumagai H, Odamaki M, et al. (2009). Impact of residual renal function on plasma levels of advanced oxidation protein products and pentosidine in peritoneal dialysis patients. Nephron Clin Pract 112:c255–61
   PubMedGoogle Scholar
• Gal-Moscovici A, Sprague SM. (2010). Use of vitamin D in chronic kidney disease patients. Kidney Int 78:146–51
   Google Scholar
• Ganji V, Kafai MR. (2006). Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Am J Clin Nutr 84:989–94
   PubMed Web of Science ®Google Scholar
• Gerdemann A, Wagner Z, Solf A, et al. (2002). Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality. Nephrol Dial Transplant 17:1045–9
   Google Scholar
• Ghiadoni L, Cupisti A, Huang Y, et al. (2004). Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 17:512–19
   PubMedGoogle Scholar
• Girotti AW. (1998). Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39:1529–42
   PubMed Web of Science ®Google Scholar
• Gocmen AY, Sahin E, Kocak H, et al. (2008). Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment. Clin Biochem 41:836–40
   PubMed Web of Science ®Google Scholar
• Guemouri L, Artur Y, Herbeth B, et al. (1991). Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 37:1932–7
   PubMed Web of Science ®Google Scholar
• Gugliucci A, Kotani K, Kimura S. (2012). Paraoxonase 1 in chronic kidney failure. J Lipids 2012:726048. doi: 10.1155/2012/726048
   PubMedGoogle Scholar
• Gutteridge JM, Halliwell B. (1990). The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129–35
   PubMed Web of Science ®Google Scholar
• Halliwell B, Chirico S. (1993). Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57:715S–24S; discussion 724S–725S
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Phinney S, Ikizler TA, et al. (2007). Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr 17:296–304
   PubMed Web of Science ®Google Scholar
• Hov GG, Sagen E, Bigonah A, Asberg A. (2007). Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography. Scand J Clin Lab Invest 67:868–76
   PubMed Web of Science ®Google Scholar
• Hwang I, Lee J, Huh JY, et al. (2012). Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61:728–38
   PubMed Web of Science ®Google Scholar
• Ikizler TA, Morrow JD, Roberts LJ, et al. (2002). Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 58:190–7
   PubMed Web of Science ®Google Scholar
• Inal M, Kanbak G, Sen S, et al. (1999). Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy. Free Radic Res 31:211–16
   PubMed Web of Science ®Google Scholar
• Jakubowski H. (2002). Homocysteine is a protein amino acid in humans: implications for homocysteine-linked disease. J Biol Chem 277:30425–8
   PubMed Web of Science ®Google Scholar
• Johnson DW, Armstrong K, Campbell SB, et al. (2007). Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 12:391–8
   PubMed Web of Science ®Google Scholar
• Kaisar M, Isbel N, Johnson DW. (2007). Cardiovascular disease in patients with chronic kidney disease: a clinical review. Minerva Urol Nefrol 59:281–97
   PubMedGoogle Scholar
• Kalogerakis G, Baker AM, Christov S, et al. (2005). Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Clin Sci (Lond) 108:497–506
   Google Scholar
• Kamat JP, Sarma HD, Devasagayam TP, et al. (1997). Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes. Mol Cell Biochem 170:131–7
   PubMed Web of Science ®Google Scholar
• Kamgar M, Zaldivar F, Vaziri ND, Pahl MV. (2009). Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. J Natl Med Assoc 101:336–44
   PubMed Web of Science ®Google Scholar
• Kan E, Undeger U, Bali M, Basaran N. (2002). Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation. Mutat Res 520:151–9
   PubMed Web of Science ®Google Scholar
• Kaneda H, Taguchi J, Ogasawara K, et al. (2002). Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162:221–5
   PubMed Web of Science ®Google Scholar
• Kannampuzha J, Donnelly SM, McFarlane PA, et al. (2010). Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis. J Ren Nutr 20:199–208
   PubMed Web of Science ®Google Scholar
• Karihtala P, Soini Y. (2007). Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 115:81–103
   PubMed Web of Science ®Google Scholar
• Karsli Ceppioglu S, Yurdun T, Canbakan M. (2011). Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease. Ren Fail 33:866–74
   Web of Science ®Google Scholar
• Keshavarzian A, Banan A, Farhadi A, et al. (2003). Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52:720–8
   PubMed Web of Science ®Google Scholar
• KHA. (2007). Chronic kidney disease (CKD) managment in general practice. Melbourne: Kidney Health Australia
   Google Scholar
• Kielstein JT, Boger RH, Bode-Boger SM, et al. (2002). Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13:170–6
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Zoccali C. (2008). Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 17:609–15
   PubMed Web of Science ®Google Scholar
• Kirmizis D, Papagianni A, Belechri AM, Memmos D. (2011). Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis. Nephrol Dial Transplant 26:2296–301
   PubMedGoogle Scholar
• Kohen R, Nyska A. (2002). Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620–50
   PubMed Web of Science ®Google Scholar
• Kuchta A, Pacanis A, Kortas-Stempak B, et al. (2011). Estimation of oxidative stress markers in chronic kidney disease. Kidney Blood Press Res 34:12–19
   PubMed Web of Science ®Google Scholar
• Kuo HT, Kuo MC, Chiu YW, et al. (2005). Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis. Eur J Clin Invest 35:245–50
   PubMed Web of Science ®Google Scholar
• Lee CY, Huang SH, Jenner AM, Halliwell B. (2008). Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Free Radic Biol Med 44:1314–22
   PubMed Web of Science ®Google Scholar
• Lee DM. (1999). A simple and sensitive method in using the ratios of cholesteryl ester molecular species as indexes of oxidative stress in plasma and lipoprotein fractions. Atherosclerosis 146:221–35
   Google Scholar
• Lee DM, Jackson KW, Knowlton N, et al. (2011). Oxidative stress and inflammation in renal patients and healthy subjects. PLoS One 6:e22360. doi: 10.1371/journal.pone.0022360
   Google Scholar
• Leitinger N. (2003). Cholesteryl ester oxidation products in atherosclerosis. Mol Aspects Med 24:239–50
   PubMedGoogle Scholar
• Lemarechal H, Allanore Y, Chenevier-Gobeaux C, et al. (2006). High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 367:156–61
   Google Scholar
• Lentini P, de Cal M, Cruz D, et al. (2010). The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. J Crit Care 25:605–9
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. doi: 10.1136/bmj.b2700
   PubMed Web of Science ®Google Scholar
• Lobo V, Patil A, Phatak A, Chandra N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 4:118–26
   PubMedGoogle Scholar
• Locatelli F, Canaud B, Eckardt KU, et al. (2003). Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272–80
   PubMed Web of Science ®Google Scholar
• Macias Nunez JF, Ghais Z, Bustamante J, et al. (2010). Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study of dialyzers membranes. Nephron Clin Pract 114:c67–73
   Google Scholar
• Mastalerz-Migas A, Reksa D, Pokorski M, et al. (2007). Comparison of a statin vs. hypolipemic diet on the oxidant status in hemodialyzed patients with chronic renal failure. J Physiol Pharmacol 58:363–70
   PubMed Web of Science ®Google Scholar
• McCord JM, Edeas MA. (2005). SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 59:139–42
   PubMed Web of Science ®Google Scholar
• Mekki K, Bouzidi-Bekada N, Kaddous A, Bouchenak M. (2010). Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. Food Funct 1:110–15
   Google Scholar
• Milne GL, Sanchez SC, Musiek ES, Morrow JD. (2007). Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2:221–6
   PubMed Web of Science ®Google Scholar
• Mimic-Oka J, Simic T, Djukanovic L, et al. (1999). Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 51:233–41
   PubMed Web of Science ®Google Scholar
• Minino AM, Smith BL. (2001). Deaths: preliminary data for 2000. Natl Vital Stat Rep 49:1–40
   Google Scholar
• Mishra V, Baines M, Perry SE, et al. (2007). Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 26:41–50
   PubMed Web of Science ®Google Scholar
• Mitrogianni Z, Barbouti A, Galaris D, Siamopoulos KC. (2009). Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin Pract 113:c234–40
   PubMedGoogle Scholar
• Miyamoto T, Rashid Qureshi A, Yamamoto T, et al. (2011). Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease. Nephrol Dial Transplant 26:2231–7
   Google Scholar
• Mo JY, Maki H, Sekiguchi M. (1992). Hydrolytic elimination of a mutagenic nucleotide 8-oxodGTP, by human 18-kilodalton protein: sanitization of nucleotide pool. Proc Natl Acad Sci USA 89:11021–5
   PubMed Web of Science ®Google Scholar
• Moller P. (2006). Assessment of reference values for DNA damage detected by the comet assay in human blood cell DNA. Mutat Res 612:84–104
   PubMed Web of Science ®Google Scholar
• Monostori P, Hracsko Z, Karg E, et al. (2009). Erythropoiesis-stimulating agent withdrawal and oxidative stress in hemodialysis. Clin Nephrol 71:521–6
   Google Scholar
• Morena M, Jaussent I, Chalabi L, et al. (2010). Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status. Hemodial Int 14:403–10
   Google Scholar
• Nakamura T, Sato E, Fujiwara N, et al. (2009). Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner. Pharmacol Res 60:525–8
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sato E, Fujiwara N, et al. (2010). Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner. Pharmacol Res 61:58–61
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sato E, Fujiwara N, et al. (2011). Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation. Metabolism 60:260–4
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sato E, Fujiwara N, et al. (2012). Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension. Am J Med Sci 343:46–51
   Google Scholar
• Nanayakkara PW, Teerlink T, Stehouwer CD, et al. (2005). Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int 68:2230–6
   PubMed Web of Science ®Google Scholar
• Nanayakkara PW, van Guldener C, Ter Wee PM, et al. (2007). Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch Intern Med 167:1262–70
   PubMedGoogle Scholar
• Nascimento MM, Suliman ME, Silva M, et al. (2010). Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int 30:336–42
   PubMed Web of Science ®Google Scholar
• Nelson SK, Bose SK, Grunwald GK, et al. (2006). The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 40:341–7
   PubMed Web of Science ®Google Scholar
• Neve J, Wasowicz W, Quivy D, et al. (1995). Lipid peroxidation assessed by serum thiobarbituric acid reactive substances in healthy subjects and in patients with pathologies known to affect trace element status. Biol Trace Elem Res 47:147–53
   Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, et al. (1997). Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43:1209–14
   PubMed Web of Science ®Google Scholar
• Niki E. (2009). Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 47:469–84
   PubMed Web of Science ®Google Scholar
• Nolin TD, Ouseph R, Himmelfarb J, et al. (2010). Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease. Clin J Am Soc Nephrol 5:1588–94
   PubMed Web of Science ®Google Scholar
• Oberg BP, Mcmenamin E, Lucas FL, et al. (2004). Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65:1009–16
   PubMed Web of Science ®Google Scholar
• Ongajooth L, Ongajyooth S, Likidlilid A, et al. (1996). Role of lipid peroxidation, trace elements and anti-oxidant enzymes in chronic renal disease patients. J Med Assoc Thai 79:791–800
   PubMedGoogle Scholar
• Palleschi S, de Angelis S, Diana L, et al. (2007). Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study. Clin Chem Lab Med 45:1211–18
   Google Scholar
• Percy C, Pat B, Poronnik P, Gobe G. (2005). Role of oxidative stress in age-associated chronic kidney pathologies. Adv Chronic Kidney Dis 12:78–83
   Google Scholar
• Pergola PE, Raskin P, Toto RD, et al. (2011). Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365:327–36
   PubMed Web of Science ®Google Scholar
• Perna AF, Ingrosso D, de Santo NG. (2003). Homocysteine and oxidative stress. Amino Acids 25:409–17
   PubMed Web of Science ®Google Scholar
• Peuchant E, Delmas-Beauvieux MC, Dubourg L, et al. (1997). Antioxidant effects of a supplemented very low protein diet in chronic renal failure. Free Radic Biol Med 22:313–20
   PubMed Web of Science ®Google Scholar
• Pryor WA. (1986). Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 48:657–67
   PubMed Web of Science ®Google Scholar
• Ramakrishna V, Jailkhani R. (2008). Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 45:41–6
   PubMed Web of Science ®Google Scholar
• Ramezani M, Nazemian F, Shamsara J, et al. (2011). Effect of omega-3 fatty acids on plasma level of 8-isoprostane in kidney transplant patients. J Ren Nutr 21:196–9
   Google Scholar
• Ramos R, Martinez-Castelao A. (2008). Lipoperoxidation and hemodialysis. Metabolism 57:1369–74
   Google Scholar
• Renke M, Tylicki L, Rutkowski P, et al. (2010). The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. Med Sci Monit 16:PI13–18
   PubMed Web of Science ®Google Scholar
• Roberts LJ 2nd, Fessel JP. (2004). The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 128:173–86
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. (2000). Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505–13
   PubMed Web of Science ®Google Scholar
• Romeu M, Nogues R, Marcas L, et al. (2010). Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study. BMC Res Notes 3:20. doi: 10.1186/1756-0500-3-20
   Google Scholar
• Rutkowski P, Malgorzewicz S, Slominska E, et al. (2006). Interrelationship between uremic toxicity and oxidative stress. J Ren Nutr 16:190–3
   PubMed Web of Science ®Google Scholar
• Rutkowski P, Slominska EM, Szolkiewicz M, et al. (2007). Relationship between uremic toxins and oxidative stress in patients with chronic renal failure. Scand J Urol Nephrol 41:243–8
   PubMed Web of Science ®Google Scholar
• Sakata T, Furuya R, Shimazu T, et al. (2008). Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients. Blood Purif 26:371–8
   PubMedGoogle Scholar
• Saran R, Novak JE, Desai A, et al. (2003). Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. Nephrol Dial Transplant 18:2415–20
   PubMed Web of Science ®Google Scholar
• Satoh M, Yamasaki Y, Nagake Y, et al. (2001). Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 59:1943–50
   PubMedGoogle Scholar
• Scholze A, Rinder C, Beige J, et al. (2004). Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation 109:369–74
   PubMed Web of Science ®Google Scholar
• Sebekova K, Gazdikova K, Syrova D, et al. (2003). Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. J Hum Hypertens 17:265–70
   PubMed Web of Science ®Google Scholar
• Seljeskog E, Hervig T, Mansoor MA. (2006). A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit. Clin Biochem 39:947–54
   PubMed Web of Science ®Google Scholar
• Shimoike T, Inoguchi T, Umeda F, et al. (2000). The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism 49:1030–5
   PubMedGoogle Scholar
• Shurtz-Swirski R, Mashiach E, Kristal B, et al. (1995). Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure. Nephron 71:176–9
   PubMed Web of Science ®Google Scholar
• Simmons EM, Langone A, Sezer MT, et al. (2005). Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79:914–19
   PubMed Web of Science ®Google Scholar
• Stepniewska J, Dolegowska B, Ciechanowski K, et al. (2006). Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions. Arch Med Res 37:353–9
   PubMed Web of Science ®Google Scholar
• Suehiro T, Ikeda Y, Shiinoki T, et al. (2002). Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis. J Atheroscler Thromb 9:133–8
   PubMedGoogle Scholar
• Suzuki D, Miyata T, Saotome N, et al. (1999). Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10:822–32
   PubMed Web of Science ®Google Scholar
• Sydow K, Munzel T. (2003). ADMA and oxidative stress. Atheroscler Suppl 4:41–51
   PubMed Web of Science ®Google Scholar
• Takahashi N, Morimoto S, Okigaki M, et al. (2011). Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients. Nephrol Dial Transplant 26:1252–7
   Google Scholar
• Tarng DC, Huang TP, Liu TY, et al. (2000). Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 58:790–9
   PubMed Web of Science ®Google Scholar
• Tarng DC, Liu TY, Huang TP. (2004). Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int 66:820–31
   Web of Science ®Google Scholar
• Tomiyama H, Watanabe G, Yoshida H, et al. (2003). Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure. Am Heart J 145:E2
   Google Scholar
• Townsend DM, Tew KD, Tapiero H. (2003). The importance of glutathione in human disease. Biomed Pharmacother 57:145–55
   PubMed Web of Science ®Google Scholar
• Tsuchikura S, Shoji T, Shimomura N, et al. (2010). Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate. BMC Nephrol 11:7. doi: 10.1186/1471-2369-11-7
   Google Scholar
• Usberti M, Gerardi G, Micheli A, et al. (2002). Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol 15:558–64
   Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. (2009). 8-Hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27:120–39
   PubMed Web of Science ®Google Scholar
• Valli A, Suliman ME, Meert N, et al. (2007). Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta 379:87–94
   PubMed Web of Science ®Google Scholar
• Vaziri ND. (2010). Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. J Ren Nutr 20:S35–43
   PubMed Web of Science ®Google Scholar
• Vincent HK, Morgan JW, Vincent KR. (2004). Obesity exacerbates oxidative stress levels after acute exercise. Med Sci Sports Exerc 36:772–9
   PubMed Web of Science ®Google Scholar
• Vural A, Yilmaz MI, Caglar K, et al. (2005). Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens. Am J Nephrol 25:250–5
   PubMed Web of Science ®Google Scholar
• Wang X, Desai K, Juurlin K, et al. (2006). Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. Kidney Int 69:281–7
   PubMed Web of Science ®Google Scholar
• Williams DR. (2012). Miles to go before we sleep. J Health Soc Behav 53:279–95
   PubMed Web of Science ®Google Scholar
• Wilund KR, Tomayko EJ., Wu PT, et al. (2010). Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study. Nephrol Dial Transplant 25:2695–701
   PubMed Web of Science ®Google Scholar
• Wiseman H, Halliwell B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17–29
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Descamps-Latsch, B. (1997). Advanced oxidation protein products: novel uraemic toxins and pro-inflammatory mediators in chronic renal failure? Nephrol Dial Transplant 12:1310–12
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–13
   PubMed Web of Science ®Google Scholar
• Yeh CC, Lai CY, Hsieh LL, et al. (2010). Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer. Carcinogenesis 31:228–33
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Saglam M, Caglar K, et al. (2006). The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47:42–50
   PubMed Web of Science ®Google Scholar
• Zachara BA, Gromadzinska J, Palus J, et al. (2011). The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study. Biol Trace Elem Res 142:274–83
   PubMedGoogle Scholar
• Zelko IN, Mariani TJ, Folz RJ. (2002). Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337–49
   PubMed Web of Science ®Google Scholar
• Zhloba AA, Blashko EL. (2004). Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 800:275–80
   Google Scholar
• Zima T, Stipek S, Crkovska J, et al. (1996). Lipid peroxidation and antioxidant enzymes in CAPD patients. Ren Fail 18:113–19
   Web of Science ®Google Scholar
• Zoccali C, Bode-Boger S, Mallamaci F, et al. (2001). Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113–17
   PubMed Web of Science ®Google Scholar